MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Evaluation of Genetic influence of APOE on Clinical and motor functions among Idiopathic Parkinson’s Disease Patients; A comparative study

W. Ibrahim, H. Shehata, L. Rashed, A. Sabbah, H. Amer (Cairo, Egypt)

Meeting: 2022 International Congress

Abstract Number: 1294

Keywords: Parkinson’s

Category: Parkinson's Disease: Genetics

Objective: We studied the effect of APOE ε4 carriers and non-carriers on clinical and motor functions in patients with IPD

Background: The significance of APOE genotype in patients with Parkinson’s Disease (PD) is controversial, but some authors suggest association of APOE e4 allele with dementia; while It’s effect on the motor symptoms is unclear.

Method: This study included 50 patients fulfilled the criteria for diagnosis of IPD based on British Brain Bank criteria.
Patients were divided into 2 groups:
Group I: included 22 patients with IPD and ε4 carrier (ε2/4, ε3/4 & ε4/4)
Group II: included 28 patients with IPD and non ε4 carrier
All patients were submitted to:
UPDRS
MRI brain
APOE Genotyping: APOE

Results: Most of the patients were APOE ε3/3 and ε3/4 genotype [Table 1].
The mean age at onset of disease was statistically significant (P=0.018) earlier in Group I patients compared to Group II [Figure 1].
The mean duration of illness was lower in Group I patients compared to Group II; but no statistically significant difference was detected.
Regarding the Predominant Type of symptoms: tremor predominant type was more in both Group I & Group II compared to Rigidity predominant type; with no statistically significant difference between both groups [Figure 2].
Although the UPDRS-Total was worse in Group I patients compared to Group II patients with mean score of 41.4 & 38.5 respectively, no statistically significant difference was detected [Figure 3].

Conclusion: APOE ε4 carriers is associated with earlier age of PD onset.
There was little evidence to support an association between APOE ε4 carriers and severity of motor features.

Table 1-1

Figure 1

Figure 2

Figure 3

References: 1. Masatoshi Takeda, Rocío Martínez, Takashi Kudo, et al.,: Apolipoprotein E and central nervous system disorders: Reviews of clinical findings. Psychiatry and Clinical Neurosciences 2010; 64: 592–607.
2. Radka Pavlova, Shima Mehrabian, Maria Petrova, et al.,: Cognitive, Neuropsychiatric, and Motor Features Associated With Apolipoprotein E e4 Allele in a Sample of Bulgarian Patients With Late-Onset Parkinson’s Disease. American Journal of Alzheimer’s Disease & Other Dementias® 1-6, 2014.

To cite this abstract in AMA style:

W. Ibrahim, H. Shehata, L. Rashed, A. Sabbah, H. Amer. Evaluation of Genetic influence of APOE on Clinical and motor functions among Idiopathic Parkinson’s Disease Patients; A comparative study [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/evaluation-of-genetic-influence-of-apoe-on-clinical-and-motor-functions-among-idiopathic-parkinsons-disease-patients-a-comparative-study/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/evaluation-of-genetic-influence-of-apoe-on-clinical-and-motor-functions-among-idiopathic-parkinsons-disease-patients-a-comparative-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley